A bacterial affliction affecting nearly a third of women worldwide may be considered a sexually transmitted infection (STI). Bacterial vaginosis (BV) occurs when the vaginal microbiome is disrupted, leading to symptoms such as itching, burning, and abnormal discharge. While BV is treatable, some women experience recurrence within 6 months, posing risks to fertility and infant health.
A new Australian study suggests that male partners can re-seed BV infections during sex if not treated properly. The trial found that simultaneous treatment of men with oral and topical antibiotics reduced the risk of recurrence by 27%. This approach could be a game-changer in treating BV, which is currently considered untreatable as an STI.
The study involved 164 monogamous couples, where one partner had BV. One group received only female treatment, while the other group also included male treatment. The results show that men play a significant role in the transmission of BV, and treating them simultaneously with women can significantly reduce recurrence rates.
Experts emphasize the need for a revolution in how BV is treated. Current standard care may not be enough to combat this STI. The study’s findings suggest that condoms are just one way to prevent BV transmission, and it’s time to start discussing the importance of male-partner treatment. Further research is needed, but this trial provides critical data to educate clinicians and patients about the role of sexual transmission and the benefits of treating male partners.
Source: https://www.sciencealert.com/common-infection-may-in-fact-be-worlds-most-prevalent-sti